Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy

被引：86

作者：

Wang, Peipei ^{[1
]}

Chen, Yueyun ^{[1
]}

Wang, Chun ^{[2
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Biotherapy, Canc Ctr,State Key Lab Biotherapy, Chengdu, Peoples R China

[2] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

tumor neoantigen burden; biomarker; immunotherapy; immune response; tumor mutation burden; T-CELL THERAPY; LUNG-CANCER; IMMUNE; PREDICTION; INHIBITORS; LANDSCAPE; RESPONSES; IMPROVE;

D O I：

10.3389/fonc.2021.672677

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunotherapy has significantly improved the clinical outcome of patients with cancer. However, the immune response rate varies greatly, possibly due to lack of effective biomarkers that can be used to distinguish responders from non-responders. Recently, clinical studies have associated high tumor neoantigen burden (TNB) with improved outcomes in patients treated with immunotherapy. Therefore, TNB has emerged as a biomarker for immunotherapy and other types of therapy. In the present review, the potential application of TNB as a biomarker was evaluated. The methods of neoantigen prediction were summarized and the mechanisms involved in TNB were investigated. The impact of high TNB and increased number of infiltrating immune cells on the efficacy of immunotherapy was also addressed. Finally, the future challenges of TNB were discussed.

引用

页数：8

共 105 条

[41] Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma [J].

Jiang, Junjie ;

Ding, Yongfeng ;

Wu, Mengjie ;

Chen, Yanyan ;

Lyu, Xiadong ;

Lu, Jun ;

Wang, Haiyong ;

Teng, Lisong .

CANCER MEDICINE, 2020, 9 (22) :8498-8518

[42] Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer [J].

Jiang, Tao ;

Cheng, Ruirui ;

Pan, Yuanwei ;

Zhang, Henghui ;

He, Ying ;

Su, Chunxia ;

Ren, Shengxiang ;

Zhou, Caicun .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) :246-+

[43] Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma [J].

Johanns, Tanner M. ;

Miller, Christopher A. ;

Liu, Connor J. ;

Perrin, Richard J. ;

Bender, Diane ;

Kobayashi, Dale K. ;

Campian, Jian L. ;

Chicoine, Michael R. ;

Dacey, Ralph G. ;

Huang, Jiayi ;

Fritsch, Edward F. ;

Gillander, William E. ;

Artyomov, Maxim N. ;

Mardis, Elaine R. ;

Schreiber, Robert D. ;

Dunn, Gavin P. .

ONCOIMMUNOLOGY, 2019, 8 (04)

[44] Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information [J].

Kim, S. ;

Kim, H. S. ;

Kim, E. ;

Lee, M. G. ;

Shin, E-C ;

Paik, S. ;

Kim, S. .

ANNALS OF ONCOLOGY, 2018, 29 (04) :1030-1036

[45] Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma [J].

Lauss, Martin ;

Donia, Marco ;

Harbst, Katja ;

Andersen, Rikke ;

Mitra, Shamik ;

Rosengren, Frida ;

Salim, Maryem ;

Vallon-Christersson, Johan ;

Torngren, Therese ;

Kvist, Anders ;

Ringner, Markus ;

Svane, Inge Marie ;

Jonsson, Goran .

NATURE COMMUNICATIONS, 2017, 8

[46] Mutational heterogeneity in cancer and the search for new cancer-associated genes [J].

Lawrence, Michael S. ;

Stojanov, Petar ;

Polak, Paz ;

Kryukov, Gregory V. ;

Cibulskis, Kristian ;

Sivachenko, Andrey ;

Carter, Scott L. ;

Stewart, Chip ;

Mermel, Craig H. ;

Roberts, Steven A. ;

Kiezun, Adam ;

Hammerman, Peter S. ;

McKenna, Aaron ;

Drier, Yotam ;

Zou, Lihua ;

Ramos, Alex H. ;

Pugh, Trevor J. ;

Stransky, Nicolas ;

Helman, Elena ;

Kim, Jaegil ;

Sougnez, Carrie ;

Ambrogio, Lauren ;

Nickerson, Elizabeth ;

Shefler, Erica ;

Cortes, Maria L. ;

Auclair, Daniel ;

Saksena, Gordon ;

Voet, Douglas ;

Noble, Michael ;

DiCara, Daniel ;

Lin, Pei ;

Lichtenstein, Lee ;

Heiman, David I. ;

Fennell, Timothy ;

Imielinski, Marcin ;

Hernandez, Bryan ;

Hodis, Eran ;

Baca, Sylvan ;

Dulak, Austin M. ;

Lohr, Jens ;

Landau, Dan-Avi ;

Wu, Catherine J. ;

Melendez-Zajgla, Jorge ;

Hidalgo-Miranda, Alfredo ;

Koren, Amnon ;

McCarroll, Steven A. ;

Mora, Jaume ;

Lee, Ryan S. ;

Crompton, Brian ;

Onofrio, Robert .

NATURE, 2013, 499 (7457) :214-218

[47] Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system [J].

Lhuillier, Claire ;

Rudqvist, Nils-Petter ;

Elemento, Olivier ;

Formenti, Silvia C. ;

Demaria, Sandra .

GENOME MEDICINE, 2019, 11 (1)

[48] Preclinical and clinical development of neoantigen vaccines [J].

Li, L. ;

Goedegebuure, S. P. ;

Gillanders, W. E. .

ANNALS OF ONCOLOGY, 2017, 28 :11-17

[49] PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity [J].

Liu, Geng ;

Li, Dongli ;

Li, Zhang ;

Qiu, Si ;

Li, Wenhui ;

Chao, Cheng-chi ;

Yang, Naibo ;

Li, Handong ;

Cheng, Zhen ;

Song, Xin ;

Cheng, Le ;

Zhang, Xiuqing ;

Wang, Jian ;

Yang, Huanming ;

Ma, Kun ;

Hou, Yong ;

Li, Bo .

GIGASCIENCE, 2017, 6 (05)

[50] Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes [J].

Lu, Tianshi ;

Wang, Shidan ;

Xu, Lin ;

Zhou, Qinbo ;

Singla, Nirmish ;

Gao, Jianjun ;

Manna, Subrata ;

Pop, Laurentiu ;

Xie, Zhiqun ;

Chen, Mingyi ;

Luke, Jason J. ;

Brugarolas, James ;

Hannan, Raquibul ;

Wang, Tao .

SCIENCE IMMUNOLOGY, 2020, 5 (44)

← 1 2 3 4 5 6 7 8 9 10 →